UPDATE | April 29, 2022

Navigating the maelstrom of M&A activity: what do CDMOs do next?

  • MAIL

 

MEDIA FOCUS 

MEDIA FOCUS

Navigating the maelstrom of M&A activity: what do CDMOs do next?

Seokjin Chang

Director of Market Intelligence

 

Finding a well-rounded service provider can be challenging, particularly in new, emerging fields such as mRNA and cell and gene therapy. In this panel discussion, Seokjin Chang, Director of Market Intelligence at Samsung Biologics, explains how finding a CDMO partner with proven end-to-end capabilities and expert personnel is the key for success. 

 

Read more 

 

MEDIA FOCUS 

MEDIA FOCUS

Navigating the maelstrom of M&A activity: what do CDMOs do next?

Seokjin Chang

Director of Market Intelligence

 

Finding a well-rounded service provider can be challenging, particularly in new, emerging fields such as mRNA and cell and gene therapy. In this panel discussion, Seokjin Chang, Director of Market Intelligence at Samsung Biologics, explains how finding a CDMO partner with proven end-to-end capabilities and expert personnel is the key for success. 

 

Read more 

  • CDO
  • CGMP
  • ADC
  • Bio Campus
  • IR
  • CMO

Share article

  • MAIL

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required